anonymous
Guest
anonymous
Guest
bRussell Sprout Bob is much worse than XRay Andrews. This company doesn't know how to hire good leaders. Tremfya was first to market and will get beaten by Abbvie with Skyrizi. Remicade was first to market and also beaten by Abbvie with Humira. No coincidence.